Opioid drug conversion guidelines vary and conflict, study says

05/14/2013 | MedPage Today (free registration)

Guidelines for opioid drug conversion vary and sometimes conflict, and are based on single-dose studies that lack long-term data, according to a Purdue Pharma study presented at APS' 32nd Annual Scientific Meeting. The biggest variation was found in recommendations for hydromorphone and oxycodone. Dr. John Peppin of the Palliative Care Center in Lexington, Ky., agreed there is a problem, and said physicians are aware of it.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ